Endovascular Management of Acute Pulmonary Embolism Using the Ultrasound-Enhanced EkoSonic System
- PMID: 26622102
- PMCID: PMC4640907
- DOI: 10.1055/s-0035-1564707
Endovascular Management of Acute Pulmonary Embolism Using the Ultrasound-Enhanced EkoSonic System
Abstract
Acute, symptomatic pulmonary embolism (PE) in the massive and submassive categories continues to be a healthcare concern with significant risk for increased morbidity and mortality. Despite increased awareness and venous thromboembolism prophylaxis, endovascular treatment is still an important option for many of these patients. There are a variety of techniques and devices used for treating PE, but none have been evaluated as extensively as the EkoSonic endovascular system that is also currently the only FDA-approved device for the treatment of pulmonary embolism. This article describes the use of the EkoSonic device for this patient population.
Keywords: EKOS; endovascular treatment; interventional radiology; pulmonary embolism; ultrasound-enhanced thrombolysis.
Figures




References
-
- Heit J A, O'Fallon W M, Petterson T M. et al.Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162(11):1245–1248. - PubMed
-
- Silverstein M D, Heit J A, Mohr D N, Petterson T M, O'Fallon W M, Melton L J III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585–593. - PubMed
-
- Rathbun S. Cardiology patient pages. The Surgeon General's call to action to prevent deep vein thrombosis and pulmonary embolism. Circulation. 2009;119(15):e480–e482. - PubMed
Publication types
LinkOut - more resources
Full Text Sources